Vectors and viruses for use in gene therapy

Details Vectors and viruses for use in gene therapy Vectors and viruses for use in gene therapy

1997-10-03

2002-01-01

Nguyen, Dave T. (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C514S04400A, C435S320100, C435S455000

Reexamination Certificate

active

06335009

ABSTRACT:

This is a national phase filing of the Application No. PCT/DE95/01817, which was filed with the Patent Corporation Treaty on Dec. 15, 1995, and is entitled to priority of the German Patent Application P 44 44 949.6, filed Dec. 16, 1994.
FIELD OF THE INVENTION
The present invention relates to vectors and viruses suitable for use in gene therapy, processes for the production thereof and their use.
BACKGROUND OF THE INVENTION
Common oncotherapy comprises the surgical removal of the tumor and the patient's aftertreatment by means of irradiation and/or systemic application of cytostatic agents. By means of the aftertreatment it is tried to kill non-removed tumor tissue and metastases formed, respectively.
However, common oncotherapies show little success. In particular, side-effects such as induction of secondary tumors, damage of internal organs or pains frequently occur in aftertreated patients.
Thus, it is the object of the present invention to provide means serving for improving common oncotherapies and avoiding particularly the above side effects.
SUMMARY OF THE INVENTION
The present invention relates to a vector suitable for use in gene therapy, which comprises an expressible insert DNA which codes for the DNA binding domain of a poly(ADP-ribose)-polymerase or for an at least partially catalytically inactive poly(ADP-ribose)-polymerase. Furthermore, this invention concerns processes for the preparation of such a vector and viruses suitable for use in gene therapy.


REFERENCES:
patent: 5449605 (1995-09-01), Smulson et al.
patent: 5585254 (1996-12-01), Maxwell et al.
patent: 0 293 193 (1988-11-01), None
Weatherall D. (British Med. Bulletin 1995, vol. 51, No. 1, pp. 1-11).*
Mastrangelo et al. (Seminars in Oncology, vol. 23, 1996, pp. 4-21).*
Kupper et al. (J. Biological Chemistry. vol. 265, 1990, pp. 18721-18724).*
Jolly D. (Cancer Gene Therapy, vol. 1, No. 1, 1994, pp. 51-64).*
Sakamoto et al. (J. Antibiotics, (1983 Mar) 36 (3) 296-300).*
Ngo et al. (in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., (ed.), Birkhauser, Boston, MA, pp. 492-495), 1994.*
Meng et al. (Gene Therapy of Cancer, Chapter 1, pp. 3-20), 1999.*
Anderson, Nature, vol. 392, pp. 25-30, 1998.*
Astell et al., 1986, “DNA Sequence of the Lymphotropic Variant of Minute Virus of Mice, MVM(i), and Comparison with the DNA Sequence of the Fibrotropic Prototype Strain,”J. Virol. 57(2):656-669.
Auer et al., 1989, “Human Nuclear NAD+ADP-Ribosyltransferase(polymerizing): Organization of the Gene,”DNA8(8):575-580.
Belt et al., 1989, “Constuction and Properties of an Epstein-Barr-Virus-Derived cDNA Expression Vector for Human Cells,”Gene84:407-417.
Kang et al., 1992, “Strategies for Expressing Analogs of PADPRP in Eukaryotic Cells,”ADP-Ribosylation React. 72-6.
Keller et al., 1985, “Expression of a Foreign Gene in Myeloid and Lymphoid Cells Derived from Multipotent Haematopoietic Precursors,”Nature318(14):149-154.
Küpper et al., 1990, “Inhibition of Poly(ADP-ribosyl)ation by Overexpressing the Poly(ADP-ribose) Polymerase DNA-binding Domain in Mammalian Cells,”J. Biol. Chem. 265(31):18721-18724.
Russell et al., 1992, “Transformation-Dependent Expression of Interleukin Genes Delivered by a Recombinant Parvovirus,”J. Virol. 66(5):2821-2828.
Samulski et al., 1987, “A Recombinant Plasmid from Which an Infectious Adeno-Associated Virus Genome Can be Excised In Vitro and Its Use to Study Viral Replication,”J. Virol. 61(10):3096-3101.

Affiliated with

Also associated with

Rating

Vectors and viruses for use in gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vectors and viruses for use in gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors and viruses for use in gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2836862